None listed
Conditions
Brief summary
This multisite prospective study will validate the SERIAS (Seizure-Related Impact Assessment Scale) for use in clinical epilepsy research and practice. 50 adult patients attending the Comprehensive Epilepsy Centres at The Alfred and The Royal Melbourne Hospital in Melbourne, Australia, will be consented and enrolled in the study. Participants will complete the novel SERIAS instrument, and a battery of validated instruments to assist with validation. These questionnaires will be completed at baseline, 3-, and 6-month timepoints. A subgroup will also form a test-retest cohort, repeating the instruments within a 2 week period.
Interventions
People living with epilepsy will prospectively be enrolled to take part in this study when they attend the hospital epilepsy service (e.g., elective hospital admission to the epilepsy ward, or routine epilepsy outpatient appointment). The study involves completing up to 9 short questionnaires regarding the effect of epilepsy on their work, quality of life, and mood, plus the study questionnaire (SERIAS). Researchers will compare how well SERIAS tracks and measures change compared to existing que
People living with epilepsy will prospectively be enrolled to take part in this study when they attend the hospital epilepsy service (e.g., elective hospital admission to the epilepsy ward, or routine epilepsy outpatient appointment). The study involves completing up to 9 short questionnaires regarding the effect of epilepsy on their work, quality of life, and mood, plus the study questionnaire (SERIAS). Researchers will compare how well SERIAS tracks and measures change compared to existing questionnaires. The questionnaires may be completed online or on paper. They will take around 20 minutes to complete. Participants are then invited to complete the same questionnaires again, 3- and 6-months later. Researchers will also review participant's medical records to mark down the type of epilepsy a person has, how frequently they have seizures, and their current treatment at each time point to see how changes in their underlying epilepsy and treatment translate to changes in their SERIAS responses. In addition, a subgroup of people will be invited to complete questionnaires at an additional time point, two weeks prior to taking the full-set of baseline questionnaires. The responses from this subgroup with help researchers confirm the test-retest reliability of SERIAS.
Sponsors
Alfred Health
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
- Adults aged 18 years and over with confirmed epilepsy and without PNES - Able to read and comprehend questionnaires
Exclusion criteria
- People aged less than 18 at time of study - Co-existing intellectual disability that would preclude people from comprehending and completing questionnaires - Limited English reading proficiency that would preclude people from comprehending and completing questionnaires - In catatonic / floridly psychotic / post-ictal state at time of questionnaire administration.
Outcome results
None listed